Marc André

Lymphoma Obinutuzumab plus Lenalidomide ( GALEN ) for the treatment of relapse / refractory aggressive lymphoma : a phase II LYSA study

R. Houot, P. Feugier, H. Tilly, 2018 .

Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).

A. Kentos, F. Offner, D. Bron, 2013 .

THE BELGIAN 2010 CONSENSUS RECOMMENDATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA

M. Vekemans, M. André, R. Schots, 2010, Acta clinica Belgica.